Directory
>
Carole Ho
Carole Ho
Director Board Of Directors | NGM Biopharmaceuticals
South San Francisco, California, United States
Carole Ho
Summary
Carole Ho is a highly accomplished Chief Medical Officer with extensive experience in clinical development and drug innovation, particularly in the fields of neurology and immunology. With a strong academic foundation from prestigious institutions like Stanford and Harvard, she has held significant leadership roles in various biotech companies, including Denali Therapeutics and Genentech. Carole's expertise encompasses a wide range of areas including biomarkers, clinical trials, and translational medicine, positioning her as a thought leader in the pharmaceutical industry. Her strategic vision and commitment to advancing medical science have driven her to publish influential research aimed at improving treatment outcomes for complex diseases like Alzheimer's. Beyond her professional achievements, Carole is actively involved in board roles, contributing to multiple organizations in the biotech sector. Her passion for innovation and dedication to patient care continue to shape her career and influence the industry.
Carole Ho
Work Experience
Director Board Of Directors at
NGM Biopharmaceuticals
June 2020 - Present
Director Board Of Directors at
Mediar Therapeutics
November 2018 - Present
Chief Medical Officer and Head of Development at
Denali Therapeutics
June 2015 - Present
Vice President, Clinical Development at
Genentech Foundation
October 2007 - June 2015
Associate Medical Director at
InBios International, Inc.
November 2006 - October 2007
Instructor at
Leland Stanford Junior University
January 2002 - January 2006
Carole Ho
Education
Stanford University, Post-Doctoral Fellowship
January 2002 - January 2007
Harvard University, Neurology Residency
January 1998 - January 2002
Joan & Sanford I. Weill Medical College of Cornell University, Md With Honors In Research
January 1993 - January 1998
Harvard University, Sb, Magna Cum Laude
January 1990 - January 1993
Illinois Mathematics and Science Academy
January 1987 - January 1990
Frequently Asked Questions about Carole Ho
What is Carole Ho email address?
Carole Ho's primary email address is ***@ngmbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Carole Ho work for?
Carole Ho is a Director Board Of Directors at NGM Biopharmaceuticals, a company specializing in Commercial physical research.
Where Carole Ho graduated from?
Carole Ho holds a degree in Neurobiology from Stanford University.
How can I directly contact Carole Ho?
To contact Carole Ho directly, you can use the email address ***@ngmbio.com. Complete contact information is available upon registration with Muraena.
Who is Carole Ho?
Carole Ho is a highly accomplished Chief Medical Officer with extensive experience in clinical development and drug innovation, particularly in the fields of neurology and immunology. With a strong academic foundation from prestigious institutions like Stanford and Harvard, she has held significant leadership roles in various biotech companies, including Denali Therapeutics and Genentech. Carole's expertise encompasses a wide range of areas including biomarkers, clinical trials, and translational medicine, positioning her as a thought leader in the pharmaceutical industry. Her strategic vision and commitment to advancing medical science have driven her to publish influential research aimed at improving treatment outcomes for complex diseases like Alzheimer's. Beyond her professional achievements, Carole is actively involved in board roles, contributing to multiple organizations in the biotech sector. Her passion for innovation and dedication to patient care continue to shape her career and influence the industry.
Carole`s contact details
***@ngmbio.com
********@gene.com
***@beamtx.com
*********@denalitherapeutics.com
Colleagues
Executive Director, Regulatory CMC
Vice President, Head of Legal
Executive Director, Project Management
Vice President, CMC & Process Development
VP Head of Biometrics
Chief Scientific Officer
Vice President, Clinical Development
CMO and Executive VP
Vice President, Clinical Operations